Your session is about to expire
← Back to Search
PET/CT Imaging for Prostate Cancer
N/A
Waitlist Available
Led By Jeffrey Y Wong
Research Sponsored by City of Hope Medical Center
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up up to 72 hours
Awards & highlights
Study Summary
This trial is looking at whether the RefleXion Medical Radiotherapy System (RMRS) can be used to image prostate cancer as well as the standard of care ([18F]-DCFPyL positron emission tomography-computed tomography (PET-CT)).
Who is the study for?
This trial is for adults over 21 with prostate cancer who are scheduled to undergo standard PET-CT imaging using a tracer that targets tumor cells. It's not suitable for individuals exceeding 450 pounds or those with psychiatric/substance abuse issues that could affect study participation.Check my eligibility
What is being tested?
The study compares the performance of RefleXion Medical Radiotherapy System (RMRS) imaging against standard PET-CT in detecting prostate cancer. The goal is to see if RMRS can improve image quality and combine scan planning with radiation therapy, potentially reducing the number of scans needed.See study design
What are the potential side effects?
Since this trial focuses on imaging techniques rather than medication, typical side effects associated with drugs aren't expected. However, exposure to radiation from PET-CT scans carries a minimal risk of long-term radiation effects.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ up to 72 hours
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~up to 72 hours
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Positron-Emission Tomography
Secondary outcome measures
Percent of cases where X1 RMRS [18F]-DCFPyL PET data can be used to generate an acceptable biology-guided radiotherapy (BgRT) plan
Trial Design
1Treatment groups
Experimental Treatment
Group I: Diagnostic ([18F]-DCFPyL PET-CT, X1 RMRS PET-CT)Experimental Treatment3 Interventions
Patients receive [18F]-DCFPyL IV and undergo [18F]-DCFPyL PET-CT over 30 minutes per SOC. Patients with PET avid lesions then undergo a X1 RMRS PET-CT imaging-only session within 120 minutes of injection over 20-35 minutes.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Positron Emission Tomography
2008
Completed Phase 2
~2240
Computed Tomography
2017
Completed Phase 2
~2720
Find a Location
Who is running the clinical trial?
City of Hope Medical CenterLead Sponsor
565 Previous Clinical Trials
1,921,430 Total Patients Enrolled
13 Trials studying Prostate Cancer
5,583 Patients Enrolled for Prostate Cancer
National Cancer Institute (NCI)NIH
13,657 Previous Clinical Trials
40,933,637 Total Patients Enrolled
560 Trials studying Prostate Cancer
507,143 Patients Enrolled for Prostate Cancer
Jeffrey Y WongPrincipal InvestigatorCity of Hope Medical Center
8 Previous Clinical Trials
195 Total Patients Enrolled
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- I am scheduled for a specific PET-CT scan before joining the study.I am scheduled for a specific PET-CT scan with [18F]-DCFPyL.I weigh less than or equal to 450 pounds.I am 21 years old or older.
Research Study Groups:
This trial has the following groups:- Group 1: Diagnostic ([18F]-DCFPyL PET-CT, X1 RMRS PET-CT)
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Are there any opportunities for subjects to enroll in this research endeavor?
"According to the information presented on clinicaltrials.gov, this trial is actively accepting applicants. It was initially posted on November 28th 2022 and last revised August 15th 2022."
Answered by AI
How many participants are currently engaged in this investigation?
"Affirmative. Details accessible on clinicaltrials.gov demonstrate that this medical investigation, which was first announced in late November 2022, is presently seeking participants. Approximately 25 patients must be enlisted from a single hospital site."
Answered by AI
Other Trials to Consider
Popular Categories
Share this study with friends
Copy Link
Messenger